Pharmaceutical Executive-05-01-2018

Pharmaceutical Executive

Brands of the Year: Promise and Challenge

May 22, 2018

Features

38

5

In its 12th annual feature, Pharm Exec builds on the revamped approach it introduced last year in spotlighting notable biopharma brands, profiling a new round of products that are making waves in five key areas in healthcare and R&D.

Gottlieb Tackles Drug Competition & Costs

May 09, 2018

Columns

38

5

Pharm Exec interviews the FDA commissioner, who is building support by combating opioid abuse and advancing innovation.

Bridging Science & Strategy: An Investor’s Eye

May 08, 2018

Features

38

5

A former biology major, biotech investment banker, and venture capitalist, Tim Sullivan brings that sought-after melding of business and scientific perspectives to his role as chief financial officer for Apellis, a clinical-stage drug company hopeful of ushering in novel protein inhibitors form autoimmune disease.

Country Report: Canada

May 01, 2018

Special Sponsored Section

38

5

Away from the glare of publicity, a tranche of bold reforms in Canada, aimed at harmonizing the national health system and delivering value for money, are fast nearing completion.

Pharmaceutical Executive, May 2018 Issue (PDF)

May 01, 2018

Issue PDF

38

5

Click the title above to open the Pharmaceutical Executive May 2018 issue in an interactive PDF format.